About the Journal

The Preclinical Studies Journal (PCS) is a peer-reviewed, open-access scientific journal published by the Academic International Society. The journal focuses on advancing research in preclinical and experimental biomedical sciences, providing an international platform for researchers, academicians, and healthcare professionals to publish high-quality scientific work.

PCS publishes original research articles, review papers, experimental studies, and short communications that contribute to the understanding of disease mechanisms, drug discovery, toxicology, molecular biology, and translational biomedical research. The journal emphasizes studies that bridge basic biomedical science and future clinical applications.

All manuscripts submitted to PCS undergo a rigorous double-blind peer-review process to ensure originality, scientific quality, and ethical research standards. The journal follows a fully open-access publishing model, ensuring that all published articles are freely accessible to readers worldwide.

PCS is committed to promoting innovative research, interdisciplinary collaboration, and the global dissemination of knowledge in preclinical biomedical sciences.

Scope

The Preclinical Studies Journal (PCS) publishes high-quality research related to preclinical, experimental, and translational biomedical sciences. The journal provides a platform for researchers, scientists, and academicians to disseminate scientific findings that contribute to the understanding of disease mechanisms, experimental therapeutics, and biomedical innovation.

The journal focuses on the following major research areas:

• Basic Biomedical Sciences
  (Anatomy, Biochemistry, Physiology, Molecular Biology, Genetics, Microbiology, and Pathology)
• Preclinical and Experimental Medicine
  (Experimental Pharmacology, Toxicology, Drug Discovery, Animal Models of Disease, Pharmacokinetics, and Biomarker Research)
• Translational Biomedical Research
  (Regenerative Medicine, Stem Cell Research, Biomedical Engineering, Disease Modeling, and Laboratory-based Therapeutics)

PCS particularly encourages research that bridges basic laboratory science with future clinical applications, contributing to advancements in biomedical research and healthcare innovation.

Copyright and Licensing

Copyright © Preclinical Studies Journal (PCS).

Authors retain copyright of their work while granting the journal the right to publish, reproduce, and distribute articles in all formats and media.

All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits sharing, copying, redistribution, adaptation, and reuse of the work for any purpose, provided appropriate credit is given to the original authors and the source.

Archiving and Digital Preservation

The Preclinical Studies Journal (PCS) is committed to the long-term preservation, accessibility, and integrity of its published content.

The journal supports digital preservation through archiving systems such as LOCKSS (Lots of Copies Keep Stuff Safe) and CLOCKSS, which maintain secure copies of journal content across a distributed network of libraries worldwide to ensure continued access to published articles.

Authors are permitted to deposit the final published version of their articles in institutional repositories, personal websites, or other scholarly archives in accordance with the journal’s archiving policy and the terms of the Creative Commons license.